Genix Acquires Exclusive Rights to SUCANON and RENOCHLOR
Genix Pharmaceuticals Corp., CA37232A1093
DGAP-News: Genix Pharmaceuticals Corp.
/ Key word(s): Miscellaneous
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
14.01.2020 / 20:42
The issuer is solely responsible for the content of this announcement.
14.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.deLanguage: English Company: Genix Pharmaceuticals Corp.
Canada ISIN: CA37232A1093 EQS News ID: 953583 End of News DGAP News Service